βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial.
Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, Collet JP, Dumaine R, Slama M, Payot L, Kasty ME, Aacha K, Vicaut E, Montalescot G; ABYSS investigators of the ACTION Study Group,.
Silvain J, et al. Among authors: delarche n.
Am Heart J. 2023 Apr;258:168-176. doi: 10.1016/j.ahj.2023.01.014. Epub 2023 Jan 20.
Am Heart J. 2023.
PMID: 36682596
Clinical Trial.